Hosted on MSN10h
Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms
Novo Nordisk reported strong early-stage results for its once-a-week obesity drug. Early Friday, Novo Nordisk stock jumped. Eli Lilly fell.
BBC22h
European Scores & Fixtures
© 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.